HELIX
Nootropic

Dihexa

Also known as PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide

Dihexa is an extremely potent nootropic peptide — reportedly 10 million times more potent than BDNF in promoting synaptogenesis. It promotes the formation of new synaptic connections and is being studied for Alzheimer's and cognitive decline. Used with caution due to potency.

Typical dosing
2–10 mg · Every few days to weekly
Administration
transdermal (DMSO), SubQ
Half-life
Unknown; effects very long-lasting
Level
advanced

How it works

Binds and activates HGF/MET receptor system, promoting angiogenesis and synaptogenesis in the brain. Activates BDNF signaling pathways at extreme potency vs exogenous BDNF.

Benefits

  • Extremely potent synaptogenesis (new synapse formation)
  • Cognitive enhancement — memory, learning, processing
  • Studied for Alzheimer's and cognitive decline treatment
  • Long-lasting effects with short dosing cycles
  • Neuroprotective

Dosing

2–10 mg · Every few days to weekly

Applied transdermally (most common — DMSO carrier) or SubQ. Due to extreme potency, dose infrequently. Effects build over time.

Ranges reflect commonly cited research protocols, not a prescription. Dose with a licensed provider.

Reconstitution

Often dissolved in DMSO for transdermal application

Helix’s free reconstitution calculator gives you the exact draw volume → get the app

Common stacks

Reported side effects

  • Unknown long-term effects
  • Potentially promotes unwanted cell growth (theoretical cancer concern at very high doses)
  • Start very low

Who it’s for

Advanced users only. Cognitive performance optimization, neurological recovery, or prevention of cognitive decline. Start with very low doses due to extreme potency.

Track Dihexa in Helix

Dose reminders, reconstitution math, vial tracking, and AI guidance — free on iOS.

Download free

RELATED COMPOUNDS